Production (Stage)
Rapid Dose Therapeutics Corp.
RDTCF
$0.1393
-$0.0407-22.61%
OTC PK
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.89M | -4.25M | -3.97M | -3.72M | -3.21M |
| Total Depreciation and Amortization | 174.10K | 267.00K | 343.90K | 412.40K | 459.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.89M | 1.93M | 1.46M | 1.17M | 701.90K |
| Change in Net Operating Assets | 986.40K | 250.90K | 62.90K | 86.80K | 363.00K |
| Cash from Operations | -838.00K | -1.80M | -2.10M | -2.05M | -1.69M |
| Capital Expenditure | -4.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -4.00K | -- | -- | -- | -- |
| Total Debt Issued | 33.80K | 157.70K | 1.22M | 2.55M | 2.75M |
| Total Debt Repaid | -412.90K | -412.10K | -596.60K | -1.45M | -1.50M |
| Issuance of Common Stock | 1.39M | 2.66M | 2.19M | 1.90M | 1.32M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -94.90K | -94.90K | -153.80K | -153.80K |
| Cash from Financing | 740.00K | 1.71M | 2.00M | 2.11M | 1.79M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | -101.90K | -92.20K | -96.50K | 61.70K | 100.70K |